StockSelector.com
  Research, Select, & Monitor Sunday, January 19, 2020 2:03:39 AM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Aclaris Therapeutics, Inc.$1.84($.13)(6.60%)

  Quote | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

Aclaris Therapeutics, Inc. has an overall rank of 5597 out of 6306 stocks based on 3 positive rankings and 4 negative rankings.

Positive Rankings
90 Day Gain
Aclaris Therapeutics rank is 242
Oversold Stochastics
Aclaris Therapeutics rank is 466
Low Put/Call
Aclaris Therapeutics has a low Put/Call ratio of 0.26 on all open interest of options expiring in the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, Aclaris Therapeutics is ranked 760.
Negative Rankings
Negative MACD Cross
The MACD Divergence has recently become negative while the MACD remains positive. This is typically a negative short-term indicator.
High vPut/Call
Aclaris Therapeutics has a high Put/Call ratio of 7.43 on active options expiring within the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, Aclaris Therapeutics is ranked 105.
Down EPS Surprise
Aclaris Therapeutics missed the consensus earnings estimate when it last reported quarterly earnings.
High/Dropping MACD
The MACD remains positive, but is dropping... suggesting a possible near-term correction. Of companies with a positive, but declining MACD, Aclaris Therapeutics is ranked 857.







Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2020 StockSelector.com. All rights reserved.